OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver-specific FGFR4 knockdown in mice on an HFD increases bile acid synthesis and improves hepatic steatosis
F. Moreau, Bruna Brasil Brunao, Xiangyu Liu, et al.
Journal of Lipid Research (2022) Vol. 64, Iss. 2, pp. 100324-100324
Open Access | Times Cited: 16

Showing 16 citing articles:

Clinical development and management of adverse events associated with FGFR inhibitors
Vivek Subbiah, Srđan Verstovšek
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101204-101204
Open Access | Times Cited: 32

Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 8

Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets
Yi Chu, Yang Su, Xiaodong Chen
Pharmacology & Therapeutics (2025), pp. 108844-108844
Closed Access

Proteomic signatures of ambient air pollution and risk of non-alcoholic fatty liver disease: A prospective cohort study in the UK Biobank
Ruxianguli Aimuzi, Zhilan Xie, Yimin Qu, et al.
The Science of The Total Environment (2024) Vol. 957, pp. 177529-177529
Closed Access | Times Cited: 3

Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases
Mohammad Almeqdadi, Fredric D. Gordon
Gastro Hep Advances (2023) Vol. 3, Iss. 3, pp. 344-352
Open Access | Times Cited: 8

The role of the gut-liver axis in modulating non-alcoholic fatty liver disease through dietary patterns and microecological agents
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 5

Dietary chromium chemical species mitigate inflammation and cholestasis in primary sclerosing cholangitis via regulating bile acid metabolism
Yu Shen, Baorong Jiang, Zejia Hao, et al.
Food Bioscience (2024) Vol. 61, pp. 104887-104887
Closed Access | Times Cited: 1

A new perspective in intestinal microecology: lifting the veil of exercise regulation of cardiometabolic diseases
Can Gao, Jiaxiao Wei, Changxu Lu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study
Shreya C. Pal, Stephany M. Castillo-Castañeda, Luis E. Díaz-Orozco, et al.
Genes (2023) Vol. 14, Iss. 10, pp. 1935-1935
Open Access | Times Cited: 2

Pathway-based similarity measurement to quantify transcriptomics similarity between human tissues and preclinical models
Paarth Parekh, Jason Sherfey, Begum Alaybeyoglu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma
Mete Ucdal, Ayşe Buruş, Başak Çeltikçi
International Journal of Hepatobiliary and Pancreatic Diseases (2024) Vol. 14, Iss. 2, pp. 1-14
Open Access

Pathway‐Based Similarity Measurement to Quantify Transcriptomics Similarity Between Human Tissues and Preclinical Models
Paarth Parekh, Jason Sherfey, Begum Alaybeyoglu, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access

Page 1

Scroll to top